BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30372675)

  • 1. Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment.
    Winston CN; Goetzl EJ; Baker LD; Vitiello MV; Rissman RA
    J Alzheimers Dis; 2018; 66(3):971-981. PubMed ID: 30372675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile.
    Winston CN; Goetzl EJ; Akers JC; Carter BS; Rockenstein EM; Galasko D; Masliah E; Rissman RA
    Alzheimers Dement (Amst); 2016; 3():63-72. PubMed ID: 27408937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial.
    Baker LD; Barsness SM; Borson S; Merriam GR; Friedman SD; Craft S; Vitiello MV
    Arch Neurol; 2012 Nov; 69(11):1420-9. PubMed ID: 22869065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the cognition-related pathogenic proteins in plasma neuronal-derived exosomes among normal cognitive adults over 45 years old with olfactory dysfunction.
    Chen Z; Chang F; Yao L; Yuan F; Hong J; Wu D; Wei Y
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3467-3476. PubMed ID: 34693486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.
    Goetzl EJ; Kapogiannis D; Schwartz JB; Lobach IV; Goetzl L; Abner EL; Jicha GA; Karydas AM; Boxer A; Miller BL
    FASEB J; 2016 Dec; 30(12):4141-4148. PubMed ID: 27601437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
    Oikonomidi A; Tautvydaitė D; Gholamrezaee MM; Henry H; Bacher M; Popp J
    J Alzheimers Dis; 2017; 60(1):273-281. PubMed ID: 28826184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction is associated with cognitive impairment in adults with OSA without dementia.
    Li M; Shen T; Yao R; Sun H; Liu X; Li Z; Zhang J
    Sleep Med; 2024 Jul; 119():234-243. PubMed ID: 38704871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Neuronal and Astrocyte Derived Exosomes From Individuals With Mild Traumatic Brain Injury for Markers of Neurodegeneration and Cytotoxic Activity.
    Winston CN; Romero HK; Ellisman M; Nauss S; Julovich DA; Conger T; Hall JR; Campana W; O'Bryant SE; Nievergelt CM; Baker DG; Risbrough VB; Rissman RA
    Front Neurosci; 2019; 13():1005. PubMed ID: 31680797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of neuronal exosomes in HIV cognitive impairment exposes sex differences.
    Sun B; Fernandes N; Pulliam L
    AIDS; 2019 Sep; 33(11):1683-1692. PubMed ID: 31149942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.
    Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU
    J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Increases Aβ140 Plasma Levels and Protects Lymphocytes from Oxidative Death in Mild Cognitive Impairment Patients.
    SanMartin CD; Henriquez M; Chacon C; Ponce DP; Salech F; Rogers NK; Behrens MI
    Curr Alzheimer Res; 2018; 15(6):561-569. PubMed ID: 29283046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Hanon O; Vidal JS; Lehmann S; Bombois S; Allinquant B; Tréluyer JM; Gelé P; Delmaire C; Blanc F; Mangin JF; Buée L; Touchon J; Hugon J; Vellas B; Galbrun E; Benetos A; Berrut G; Paillaud E; Wallon D; Castelnovo G; Volpe-Gillot L; Paccalin M; Robert PH; Godefroy O; Dantoine T; Camus V; Belmin J; Vandel P; Novella JL; Duron E; Rigaud AS; Schraen-Maschke S; Gabelle A;
    Alzheimers Dement; 2018 Jul; 14(7):858-868. PubMed ID: 29458036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging.
    Friedman SD; Baker LD; Borson S; Jensen JE; Barsness SM; Craft S; Merriam GR; Otto RK; Novotny EJ; Vitiello MV
    JAMA Neurol; 2013 Jul; 70(7):883-90. PubMed ID: 23689947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind, Placebo-Controlled Trial.
    Bai D; Fan J; Li M; Dong C; Gao Y; Fu M; Huang G; Liu H
    J Alzheimers Dis; 2021; 81(1):155-167. PubMed ID: 33749643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A
    J Alzheimers Dis; 2015; 45(4):1077-88. PubMed ID: 25649653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-derived plasma exosome proteins in Alzheimer's disease angiopathy.
    Abner EL; Elahi FM; Jicha GA; Mustapic M; Al-Janabi O; Kramer JH; Kapogiannis D; Goetzl EJ
    FASEB J; 2020 Apr; 34(4):5967-5974. PubMed ID: 32157747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
    J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.